CD34 and acute myeloid leukemia: Houtsma et al. explored the expression of CD123, as well as of other LSC surface markers in CD34+ cells of 256 AML samples; a significantly increased CD123 expression compared to normal bone marrow cells was observed in de novo AMLs and in tAMLs but not in sAMLs [33].